A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News

Published on Wednesday 05 November 2008 - 17:19

Summary :
Last week brought an interesting mix of theory and practice about the impact of the current economic climate on life sciences.' There was a flurry of news related to natalizumab (Tysabri), the...
Read more

Information source

Xconomy

http://www.xconomy.com

Website description
Business + Technology in the Exponential Economy

Articles published on this website : 2 / 7 days - 3 / 30 days

Archemix Partners with GSK, EMC Acquires SourceLabs Assets, Huya Bioscience Taps Into China For Novel Drug Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue India’s Innovation Front Lines, Part 3: Of Property Ceregene Drug Fails in Parkinson’s Trial

Other articles published on other websites on the same day

Pet therapy program Nov. 7 http://www.hannibal.net/ Obama Pick: StemCells Inc. http://www.bloggingstocks.com/ Vitamin B3 may reduce Alzheimer's symptoms http://www.timesoftheinternet.com/ Vitamin B3 may help those with Alzheimer http://www.healthjockey.com/ Caution urged over using vitamin B3 to treat Alzheimer's http://www.ireland.com/ Common vitamin may protect against Alzheimer's disease http://3news.co.nz/ Other illnesses affect Alzheimer's disease'survival http://www.healthcentral.com/ Other illnesses affect Alzheimer's disease survival http://www.reuters.com/ Physicians Adult Daycare, Inc. Celebrates National Family Caregivers Month, National Alzheimer's Disease Month http://www.redorbit.com/ Alzheimer's Society Comment On Nicotinamide Vitamin B3 Study In Journal Of Neuroscience http://www.medicalnewstoday.com/